Ergoteles’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,788
| Closed | -$318K | – | 267 |
|
|
2023
Q2 | $318K | Sell |
10,788
-26,703
| -71% | -$788K | 0.02% | 752 |
|
|
2023
Q1 | $864K | Buy |
+37,491
| New | +$864K | 0.03% | 550 |
|
|
2022
Q2 | – | Sell |
-6,693
| Closed | -$215K | – | 1714 |
|
|
2022
Q1 | $215K | Buy |
+6,693
| New | +$215K | 0.01% | 961 |
|
|
2021
Q2 | – | Sell |
-10,300
| Closed | -$588K | – | 1529 |
|
|
2021
Q1 | $588K | Buy |
+10,300
| New | +$588K | 0.02% | 452 |
|